Over 1850 Total Lots Up For Auction at Six Locations - MA 04/30, NJ Cleansweep 05/02, TX 05/03, TX 05/06, NJ 05/08, WA 05/09

Best of 2016: thought leaders honored by health care associations

December 27, 2016
Business Affairs
From the December 2016 issue of HealthCare Business News magazine

He was the CTO of CoreLab Partners (formerly RadPharm), until it was acquired by BioClinica, and prior to that was medical imaging products director of development at ComView Corporation, director of medical imaging technology at Quintiles Intelligent Imaging and before that, lead designer for DICOM Standardization at GE Medical Systems. Current special interests include standard reporting of quantitative imaging results, radiation dose structured reporting, standardization of imaging procedure codes and ontologies, modeling of imaging procedures and de-identification of imaging data for secondary reuse.

Paul C. Aebersold Award
The Paul C. Aebersold Award is named after a pioneer in the biologic and medical application of radioactive materials and the first director of the Atomic Energy Commission’s Division of Isotope Development. The award recognizes outstanding achievement in basic science applied to nuclear medicine and was first presented in 1973. The SNMMI Committee on Awards selects the recipient. Dr. Peter S. Conti, FACNP, FACR, professor of radiology, pharmaceutical sciences and biomedical engineering, and director of the Molecular Imaging Center, Keck School of Medicine, University of Southern California, Los Angeles, has been named the 2016 recipient of the prestigious Paul C. Aebersold Award.

A tenured professor at the University of Southern California, Conti has served as director of the university’s Molecular Imaging Center (formerly the Positron Imaging Science Center and Clinic) since its inception in 1991. His research focuses on development of novel diagnostic imaging agents for oncology applications. He pioneered the use of PET imaging in the understanding and characterization of cancer metabolism and gene expression, and he has focused on the discovery and clinical translation of novel PET imaging agents for in vivo cancer diagnosis, evaluation of metastatic disease potential and assessment of response to therapy.

Dr. Peter S. Conti

Conti received his medical degree from Cornell University Medical College and his doctorate in biophysics from Cornell University Graduate School of Medical Sciences, Sloan-Kettering Division, New York, N.Y. He completed his residency in diagnostic radiology and fellowship in nuclear medicine at Johns Hopkins Medical Institutions, Baltimore, and interned in the Department of Surgery at St. Luke’s Hospital in New York. Conti is board certified in both diagnostic radiology and nuclear medicine. He is a fellow of the American College of Radiology and the American College of Nuclear Medicine Physicians. He has published more than 300 peer-reviewed scientific articles and abstracts in the field of molecular imaging. Conti is a past president of the Society of Nuclear Medicine and remains active in the society (now called the Society of Nuclear Medicine and Molecular Imaging), serving on a number of committees, including government and regulatory affairs related to the development of molecular imaging technology and its applications in medicine.

You Must Be Logged In To Post A Comment